Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Receivables (2023 - 2025)

BrightSpring Health Services' Receivables history spans 3 years, with the latest figure at $1.0 billion for Q4 2025.

  • For Q4 2025, Receivables rose 8.41% year-over-year to $1.0 billion; the TTM value through Dec 2025 reached $1.0 billion, up 8.41%, while the annual FY2025 figure was $1.0 billion, 8.41% up from the prior year.
  • Receivables reached $1.0 billion in Q4 2025 per BTSG's latest filing, down from $1.0 billion in the prior quarter.
  • In the past five years, Receivables ranged from a high of $1.1 billion in Q3 2024 to a low of $948.2 million in Q4 2024.
  • Average Receivables over 3 years is $1.0 billion, with a median of $1.0 billion recorded in 2025.
  • The largest YoY upside for Receivables was 8.41% in 2025 against a maximum downside of 3.94% in 2025.
  • A 3-year view of Receivables shows it stood at $948.8 million in 2023, then decreased by 0.06% to $948.2 million in 2024, then grew by 8.41% to $1.0 billion in 2025.
  • Per Business Quant, the three most recent readings for BTSG's Receivables are $1.0 billion (Q4 2025), $1.0 billion (Q3 2025), and $1.0 billion (Q2 2025).